ID   SCOT1_HUMAN             Reviewed;         520 AA.
AC   P55809; B2R5V2; B7Z528;
DT   01-NOV-1997, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1997, sequence version 1.
DT   15-MAR-2017, entry version 165.
DE   RecName: Full=Succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial;
DE            EC=2.8.3.5;
DE   AltName: Full=3-oxoacid CoA-transferase 1;
DE   AltName: Full=Somatic-type succinyl-CoA:3-oxoacid CoA-transferase;
DE            Short=SCOT-s;
DE   Flags: Precursor;
GN   Name=OXCT1; Synonyms=OXCT, SCOT;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND PARTIAL PROTEIN SEQUENCE.
RC   TISSUE=Heart;
RX   PubMed=8751852;
RA   Kassovska-Bratinova S., Fukao T., Song X.-Q., Duncan A.M.V.,
RA   Chen H.S., Robert M.-F., Perez-Cerda C., Ugarte M., Chartrand C.,
RA   Vobecky S., Kondo N., Mitchell G.A.;
RT   "Succinyl CoA:3-oxoacid CoA transferase (SCOT): human cDNA cloning,
RT   human chromosomal mapping to 5p13, and mutation detection in a SCOT-
RT   deficient patient.";
RL   Am. J. Hum. Genet. 59:519-528(1996).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND VARIANTS SCOTD GLU-219; MET-221
RP   AND GLU-324.
RX   PubMed=10964512; DOI=10.1006/geno.2000.6282;
RA   Fukao T., Mitchell G.A., Song X.-Q., Nakamura H.,
RA   Kassovska-Bratinova S., Orii K.E., Wraith J.E., Besley G.,
RA   Wanders R.J.A., Niezen-Koning K.E., Berry G.T., Palmieri M., Kondo N.;
RT   "Succinyl-CoA:3-ketoacid CoA transferase (SCOT): cloning of the human
RT   SCOT gene, tertiary structural modeling of the human SCOT monomer, and
RT   characterization of three pathogenic mutations.";
RL   Genomics 68:144-151(2000).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15372022; DOI=10.1038/nature02919;
RA   Schmutz J., Martin J., Terry A., Couronne O., Grimwood J., Lowry S.,
RA   Gordon L.A., Scott D., Xie G., Huang W., Hellsten U., Tran-Gyamfi M.,
RA   She X., Prabhakar S., Aerts A., Altherr M., Bajorek E., Black S.,
RA   Branscomb E., Caoile C., Challacombe J.F., Chan Y.M., Denys M.,
RA   Detter J.C., Escobar J., Flowers D., Fotopulos D., Glavina T.,
RA   Gomez M., Gonzales E., Goodstein D., Grigoriev I., Groza M.,
RA   Hammon N., Hawkins T., Haydu L., Israni S., Jett J., Kadner K.,
RA   Kimball H., Kobayashi A., Lopez F., Lou Y., Martinez D., Medina C.,
RA   Morgan J., Nandkeshwar R., Noonan J.P., Pitluck S., Pollard M.,
RA   Predki P., Priest J., Ramirez L., Retterer J., Rodriguez A.,
RA   Rogers S., Salamov A., Salazar A., Thayer N., Tice H., Tsai M.,
RA   Ustaszewska A., Vo N., Wheeler J., Wu K., Yang J., Dickson M.,
RA   Cheng J.-F., Eichler E.E., Olsen A., Pennacchio L.A., Rokhsar D.S.,
RA   Richardson P., Lucas S.M., Myers R.M., Rubin E.M.;
RT   "The DNA sequence and comparative analysis of human chromosome 5.";
RL   Nature 431:268-274(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2).
RC   TISSUE=Cerebellum, and Kidney;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Brain;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   PROTEIN SEQUENCE OF 40-50.
RC   TISSUE=Colon;
RA   Reymond M.A., Sanchez J.-C., Hughes G.J., Riese J., Tortola S.,
RA   Peinado M.A., Kirchner T., Hohenberger W., Hochstrasser D.F.,
RA   Kockerling F.;
RL   Submitted (FEB-1997) to UniProtKB.
RN   [7]
RP   PROTEIN SEQUENCE OF 84-104; 111-124; 147-173; 191-211; 391-418;
RP   422-434 AND 501-511, AND IDENTIFICATION BY MASS SPECTROMETRY.
RC   TISSUE=Brain, Cajal-Retzius cell, and Fetal brain cortex;
RA   Lubec G., Afjehi-Sadat L., Chen W.-Q., Sun Y.;
RL   Submitted (DEC-2008) to UniProtKB.
RN   [8]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19608861; DOI=10.1126/science.1175371;
RA   Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M.,
RA   Walther T.C., Olsen J.V., Mann M.;
RT   "Lysine acetylation targets protein complexes and co-regulates major
RT   cellular functions.";
RL   Science 325:834-840(2009).
RN   [9]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-170, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S.,
RA   Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full
RT   phosphorylation site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [10]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [11]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M.,
RA   Ayoub D., Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
RN   [12]
RP   X-RAY CRYSTALLOGRAPHY (2.2 ANGSTROMS) OF 40-520.
RG   Structural genomics consortium (SGC);
RT   "Crystal structure of human 3-oxoacid CoA transferase 1.";
RL   Submitted (AUG-2008) to the PDB data bank.
RN   [13]
RP   VARIANTS SCOTD GLU-133 AND PHE-456, AND VARIANT MET-58.
RX   PubMed=9671268;
RX   DOI=10.1002/(SICI)1098-1004(1998)12:2<83::AID-HUMU2>3.0.CO;2-P;
RA   Song X.-Q., Fukao T., Watanabe H., Shintaku H., Hirayama K.,
RA   Kassovska-Bratinova S., Kondo N., Mitchell G.A.;
RT   "Succinyl-CoA:3-ketoacid CoA transferase (SCOT) deficiency: two
RT   pathogenic mutations, V133E and C456F, in Japanese siblings.";
RL   Hum. Mutat. 12:83-88(1998).
RN   [14]
RP   VARIANTS SCOTD VAL-215; ASN-226; PRO-327; PHE-404; PRO-405 AND
RP   CYS-468, VARIANT MET-58, AND CHARACTERIZATION OF VARIANTS SCOTD
RP   VAL-215; ASN-226; PRO-327; PHE-404; PRO-405 AND CYS-468.
RX   PubMed=21296660; DOI=10.1016/j.bbadis.2011.01.015;
RA   Fukao T., Sass J.O., Kursula P., Thimm E., Wendel U., Ficicioglu C.,
RA   Monastiri K., Guffon N., Baric I., Zabot M.T., Kondo N.;
RT   "Clinical and molecular characterization of five patients with
RT   succinyl-CoA:3-ketoacid CoA transferase (SCOT) deficiency.";
RL   Biochim. Biophys. Acta 1812:619-624(2011).
CC   -!- FUNCTION: Key enzyme for ketone body catabolism. Transfers the CoA
CC       moiety from succinate to acetoacetate. Formation of the enzyme-CoA
CC       intermediate proceeds via an unstable anhydride species formed
CC       between the carboxylate groups of the enzyme and substrate.
CC   -!- CATALYTIC ACTIVITY: Succinyl-CoA + a 3-oxo acid = succinate + a 3-
CC       oxoacyl-CoA. {ECO:0000255|PROSITE-ProRule:PRU10034}.
CC   -!- PATHWAY: Ketone metabolism; succinyl-CoA degradation; acetoacetyl-
CC       CoA from succinyl-CoA: step 1/1.
CC   -!- SUBUNIT: Homodimer.
CC   -!- SUBCELLULAR LOCATION: Mitochondrion matrix.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=P55809-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=P55809-2; Sequence=VSP_056310;
CC         Note=No experimental confirmation available.;
CC   -!- TISSUE SPECIFICITY: Abundant in heart, followed in order by
CC       kidney, brain, and muscle, whereas in liver it is undetectable;
CC       also detectable in leukocytes and fibroblasts.
CC   -!- DISEASE: Succinyl-CoA:3-oxoacid CoA transferase deficiency (SCOTD)
CC       [MIM:245050]: A disorder of ketone body metabolism, characterized
CC       by episodic ketoacidosis. Patients are usually asymptomatic
CC       between episodes. {ECO:0000269|PubMed:10964512,
CC       ECO:0000269|PubMed:21296660, ECO:0000269|PubMed:9671268}. Note=The
CC       disease is caused by mutations affecting the gene represented in
CC       this entry.
CC   -!- SIMILARITY: Belongs to the 3-oxoacid CoA-transferase family.
CC       {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; U62961; AAB07366.1; -; mRNA.
DR   EMBL; AB029576; BAB13733.1; -; Genomic_DNA.
DR   EMBL; AK298352; BAH12764.1; -; mRNA.
DR   EMBL; AK312327; BAG35249.1; -; mRNA.
DR   EMBL; AK315902; BAH14273.1; -; mRNA.
DR   EMBL; AC008817; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC034222; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC114946; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC009001; AAH09001.1; -; mRNA.
DR   CCDS; CCDS3937.1; -. [P55809-1]
DR   RefSeq; NP_000427.1; NM_000436.3. [P55809-1]
DR   UniGene; Hs.278277; -.
DR   PDB; 3DLX; X-ray; 2.20 A; A/B/C/D=40-520.
DR   PDBsum; 3DLX; -.
DR   ProteinModelPortal; P55809; -.
DR   SMR; P55809; -.
DR   BioGrid; 111059; 64.
DR   IntAct; P55809; 5.
DR   STRING; 9606.ENSP00000196371; -.
DR   DrugBank; DB02731; Ethylmercurithiosalicylic acid.
DR   DrugBank; DB00139; Succinic acid.
DR   iPTMnet; P55809; -.
DR   PhosphoSitePlus; P55809; -.
DR   BioMuta; OXCT1; -.
DR   DMDM; 2492998; -.
DR   UCD-2DPAGE; P55809; -.
DR   EPD; P55809; -.
DR   MaxQB; P55809; -.
DR   PaxDb; P55809; -.
DR   PeptideAtlas; P55809; -.
DR   PRIDE; P55809; -.
DR   DNASU; 5019; -.
DR   Ensembl; ENST00000196371; ENSP00000196371; ENSG00000083720. [P55809-1]
DR   Ensembl; ENST00000510634; ENSP00000423144; ENSG00000083720. [P55809-2]
DR   Ensembl; ENST00000512084; ENSP00000421143; ENSG00000083720. [P55809-2]
DR   GeneID; 5019; -.
DR   KEGG; hsa:5019; -.
DR   UCSC; uc003jmn.4; human. [P55809-1]
DR   CTD; 5019; -.
DR   DisGeNET; 5019; -.
DR   GeneCards; OXCT1; -.
DR   HGNC; HGNC:8527; OXCT1.
DR   HPA; HPA012047; -.
DR   HPA; HPA061425; -.
DR   MalaCards; OXCT1; -.
DR   MIM; 245050; phenotype.
DR   MIM; 601424; gene.
DR   neXtProt; NX_P55809; -.
DR   OpenTargets; ENSG00000083720; -.
DR   Orphanet; 832; Succinyl-CoA:3-ketoacid CoA transferase deficiency.
DR   PharmGKB; PA32855; -.
DR   eggNOG; KOG3822; Eukaryota.
DR   eggNOG; COG1788; LUCA.
DR   eggNOG; COG2057; LUCA.
DR   GeneTree; ENSGT00390000009130; -.
DR   HOGENOM; HOG000221245; -.
DR   HOVERGEN; HBG002310; -.
DR   InParanoid; P55809; -.
DR   KO; K01027; -.
DR   OMA; NIQFRHA; -.
DR   OrthoDB; EOG091G0D3X; -.
DR   PhylomeDB; P55809; -.
DR   TreeFam; TF313991; -.
DR   BioCyc; MetaCyc:HS01447-MONOMER; -.
DR   BRENDA; 2.8.3.5; 2681.
DR   Reactome; R-HSA-77108; Utilization of Ketone Bodies.
DR   UniPathway; UPA00929; UER00894.
DR   EvolutionaryTrace; P55809; -.
DR   GeneWiki; OXCT1; -.
DR   GenomeRNAi; 5019; -.
DR   PRO; PR:P55809; -.
DR   Proteomes; UP000005640; Chromosome 5.
DR   Bgee; ENSG00000083720; -.
DR   CleanEx; HS_OXCT1; -.
DR   ExpressionAtlas; P55809; baseline and differential.
DR   Genevisible; P55809; HS.
DR   GO; GO:0005759; C:mitochondrial matrix; TAS:Reactome.
DR   GO; GO:0005739; C:mitochondrion; IDA:UniProtKB.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0008260; F:3-oxoacid CoA-transferase activity; IMP:UniProtKB.
DR   GO; GO:0042803; F:protein homodimerization activity; NAS:UniProtKB.
DR   GO; GO:0060612; P:adipose tissue development; IEA:Ensembl.
DR   GO; GO:0007420; P:brain development; IEA:Ensembl.
DR   GO; GO:0046950; P:cellular ketone body metabolic process; IMP:UniProtKB.
DR   GO; GO:0007507; P:heart development; IEA:Ensembl.
DR   GO; GO:0046952; P:ketone body catabolic process; TAS:Reactome.
DR   GO; GO:0042182; P:ketone catabolic process; IEA:Ensembl.
DR   GO; GO:0035774; P:positive regulation of insulin secretion involved in cellular response to glucose stimulus; IEA:Ensembl.
DR   GO; GO:0014823; P:response to activity; IEA:Ensembl.
DR   GO; GO:0042493; P:response to drug; IEA:Ensembl.
DR   GO; GO:0045471; P:response to ethanol; IEA:Ensembl.
DR   GO; GO:0009725; P:response to hormone; IEA:Ensembl.
DR   GO; GO:0007584; P:response to nutrient; IEA:Ensembl.
DR   GO; GO:0042594; P:response to starvation; IEA:Ensembl.
DR   InterPro; IPR012792; 3-oxoacid_CoA-transf_A.
DR   InterPro; IPR012791; 3-oxoacid_CoA-transf_B.
DR   InterPro; IPR014388; 3-oxoacid_CoA-transferase.
DR   InterPro; IPR004165; CoA_trans_fam_I.
DR   InterPro; IPR004164; CoA_transf_AS.
DR   InterPro; IPR004163; CoA_transf_BS.
DR   PANTHER; PTHR13707; PTHR13707; 1.
DR   Pfam; PF01144; CoA_trans; 2.
DR   PIRSF; PIRSF000858; SCOT-t; 1.
DR   SMART; SM00882; CoA_trans; 2.
DR   TIGRFAMs; TIGR02429; pcaI_scoA_fam; 1.
DR   TIGRFAMs; TIGR02428; pcaJ_scoB_fam; 1.
DR   PROSITE; PS01273; COA_TRANSF_1; 1.
DR   PROSITE; PS01274; COA_TRANSF_2; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Complete proteome;
KW   Direct protein sequencing; Disease mutation; Mitochondrion;
KW   Phosphoprotein; Polymorphism; Reference proteome; Transferase;
KW   Transit peptide.
FT   TRANSIT       1     39       Mitochondrion. {ECO:0000269|Ref.6}.
FT   CHAIN        40    520       Succinyl-CoA:3-ketoacid coenzyme A
FT                                transferase 1, mitochondrial.
FT                                /FTId=PRO_0000002413.
FT   ACT_SITE    344    344       5-glutamyl coenzyme A thioester
FT                                intermediate. {ECO:0000255|PROSITE-
FT                                ProRule:PRU10034}.
FT   MOD_RES     170    170       Phosphoserine.
FT                                {ECO:0000244|PubMed:20068231}.
FT   MOD_RES     185    185       N6-succinyllysine.
FT                                {ECO:0000250|UniProtKB:Q9D0K2}.
FT   MOD_RES     418    418       N6-succinyllysine.
FT                                {ECO:0000250|UniProtKB:Q9D0K2}.
FT   MOD_RES     421    421       N6-succinyllysine.
FT                                {ECO:0000250|UniProtKB:Q9D0K2}.
FT   MOD_RES     455    455       N6-succinyllysine.
FT                                {ECO:0000250|UniProtKB:Q9D0K2}.
FT   VAR_SEQ       1    397       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_056310.
FT   VARIANT      58     58       T -> M (in dbSNP:rs75134564).
FT                                {ECO:0000269|PubMed:21296660,
FT                                ECO:0000269|PubMed:9671268}.
FT                                /FTId=VAR_000695.
FT   VARIANT     133    133       V -> E (in SCOTD; dbSNP:rs267606930).
FT                                {ECO:0000269|PubMed:9671268}.
FT                                /FTId=VAR_000696.
FT   VARIANT     215    215       A -> V (in SCOTD; partial loss of
FT                                activity; dbSNP:rs201752548).
FT                                {ECO:0000269|PubMed:21296660}.
FT                                /FTId=VAR_065564.
FT   VARIANT     219    219       G -> E (in SCOTD; dbSNP:rs121909302).
FT                                {ECO:0000269|PubMed:10964512}.
FT                                /FTId=VAR_010337.
FT   VARIANT     221    221       V -> M (in SCOTD; dbSNP:rs121909303).
FT                                {ECO:0000269|PubMed:10964512}.
FT                                /FTId=VAR_010338.
FT   VARIANT     226    226       S -> N (in SCOTD; loss of activity;
FT                                dbSNP:rs368841359).
FT                                {ECO:0000269|PubMed:21296660}.
FT                                /FTId=VAR_065565.
FT   VARIANT     324    324       G -> E (in SCOTD; dbSNP:rs121909301).
FT                                {ECO:0000269|PubMed:10964512}.
FT                                /FTId=VAR_010339.
FT   VARIANT     327    327       L -> P (in SCOTD; partial loss of
FT                                activity). {ECO:0000269|PubMed:21296660}.
FT                                /FTId=VAR_065566.
FT   VARIANT     404    404       V -> F (in SCOTD; loss of activity).
FT                                {ECO:0000269|PubMed:21296660}.
FT                                /FTId=VAR_065567.
FT   VARIANT     405    405       S -> P (in SCOTD; loss of activity).
FT                                {ECO:0000269|PubMed:21296660}.
FT                                /FTId=VAR_065568.
FT   VARIANT     456    456       C -> F (in SCOTD; dbSNP:rs121909300).
FT                                {ECO:0000269|PubMed:9671268}.
FT                                /FTId=VAR_000697.
FT   VARIANT     468    468       R -> C (in SCOTD; partial loss of
FT                                activity; the mutant retains half of the
FT                                activity of the wild-type at 30 degrees).
FT                                {ECO:0000269|PubMed:21296660}.
FT                                /FTId=VAR_065569.
FT   CONFLICT     95     95       D -> G (in Ref. 4; BAG35249).
FT                                {ECO:0000305}.
FT   STRAND       41     44       {ECO:0000244|PDB:3DLX}.
FT   HELIX        46     50       {ECO:0000244|PDB:3DLX}.
FT   STRAND       58     61       {ECO:0000244|PDB:3DLX}.
FT   HELIX        71     80       {ECO:0000244|PDB:3DLX}.
FT   STRAND       84     88       {ECO:0000244|PDB:3DLX}.
FT   HELIX       100    104       {ECO:0000244|PDB:3DLX}.
FT   STRAND      108    114       {ECO:0000244|PDB:3DLX}.
FT   HELIX       120    127       {ECO:0000244|PDB:3DLX}.
FT   STRAND      130    135       {ECO:0000244|PDB:3DLX}.
FT   HELIX       138    150       {ECO:0000244|PDB:3DLX}.
FT   STRAND      154    158       {ECO:0000244|PDB:3DLX}.
FT   TURN        159    162       {ECO:0000244|PDB:3DLX}.
FT   HELIX       164    167       {ECO:0000244|PDB:3DLX}.
FT   STRAND      171    174       {ECO:0000244|PDB:3DLX}.
FT   STRAND      178    183       {ECO:0000244|PDB:3DLX}.
FT   STRAND      189    192       {ECO:0000244|PDB:3DLX}.
FT   STRAND      195    201       {ECO:0000244|PDB:3DLX}.
FT   STRAND      205    211       {ECO:0000244|PDB:3DLX}.
FT   STRAND      213    216       {ECO:0000244|PDB:3DLX}.
FT   HELIX       225    227       {ECO:0000244|PDB:3DLX}.
FT   HELIX       231    234       {ECO:0000244|PDB:3DLX}.
FT   STRAND      237    249       {ECO:0000244|PDB:3DLX}.
FT   HELIX       256    258       {ECO:0000244|PDB:3DLX}.
FT   HELIX       263    265       {ECO:0000244|PDB:3DLX}.
FT   STRAND      268    271       {ECO:0000244|PDB:3DLX}.
FT   HELIX       300    309       {ECO:0000244|PDB:3DLX}.
FT   HELIX       310    312       {ECO:0000244|PDB:3DLX}.
FT   STRAND      318    321       {ECO:0000244|PDB:3DLX}.
FT   HELIX       325    329       {ECO:0000244|PDB:3DLX}.
FT   HELIX       330    332       {ECO:0000244|PDB:3DLX}.
FT   STRAND      340    343       {ECO:0000244|PDB:3DLX}.
FT   TURN        344    346       {ECO:0000244|PDB:3DLX}.
FT   STRAND      347    350       {ECO:0000244|PDB:3DLX}.
FT   HELIX       356    358       {ECO:0000244|PDB:3DLX}.
FT   STRAND      368    370       {ECO:0000244|PDB:3DLX}.
FT   STRAND      373    379       {ECO:0000244|PDB:3DLX}.
FT   HELIX       382    390       {ECO:0000244|PDB:3DLX}.
FT   STRAND      395    399       {ECO:0000244|PDB:3DLX}.
FT   STRAND      402    405       {ECO:0000244|PDB:3DLX}.
FT   STRAND      413    415       {ECO:0000244|PDB:3DLX}.
FT   TURN        416    418       {ECO:0000244|PDB:3DLX}.
FT   HELIX       426    429       {ECO:0000244|PDB:3DLX}.
FT   STRAND      435    440       {ECO:0000244|PDB:3DLX}.
FT   HELIX       446    448       {ECO:0000244|PDB:3DLX}.
FT   STRAND      450    455       {ECO:0000244|PDB:3DLX}.
FT   STRAND      461    464       {ECO:0000244|PDB:3DLX}.
FT   STRAND      468    470       {ECO:0000244|PDB:3DLX}.
FT   STRAND      472    479       {ECO:0000244|PDB:3DLX}.
FT   TURN        480    482       {ECO:0000244|PDB:3DLX}.
FT   STRAND      483    489       {ECO:0000244|PDB:3DLX}.
FT   HELIX       495    499       {ECO:0000244|PDB:3DLX}.
FT   STRAND      502    504       {ECO:0000244|PDB:3DLX}.
FT   STRAND      507    514       {ECO:0000244|PDB:3DLX}.
SQ   SEQUENCE   520 AA;  56158 MW;  54DA790FB8EDA546 CRC64;
     MAALKLLSSG LRLCASARGS GATWYKGCVC SFSTSAHRHT KFYTDPVEAV KDIPDGATVL
     VGGFGLCGIP ENLIDALLKT GVKGLTAVSN NAGVDNFGLG LLLRSKQIKR MVSSYVGENA
     EFERQYLSGE LEVELTPQGT LAERIRAGGA GVPAFYTPTG YGTLVQEGGS PIKYNKDGSV
     AIASKPREVR EFNGQHFILE EAITGDFALV KAWKADRAGN VIFRKSARNF NLPMCKAAET
     TVVEVEEIVD IGAFAPEDIH IPQIYVHRLI KGEKYEKRIE RLSIRKEGDG EAKSAKPGDD
     VRERIIKRAA LEFEDGMYAN LGIGIPLLAS NFISPNITVH LQSENGVLGL GPYPRQHEAD
     ADLINAGKET VTILPGASFF SSDESFAMIR GGHVDLTMLG AMQVSKYGDL ANWMIPGKMV
     KGMGGAMDLV SSAKTKVVVT MEHSAKGNAH KIMEKCTLPL TGKQCVNRII TEKAVFDVDK
     KKGLTLIELW EGLTVDDVQK STGCDFAVSP KLMPMQQIAN
//
